Neoadjuvant chemotherapy (NACT) increases immune infiltration and programmed death-ligand 1 (PD-L1) expression in epithelial ovarian cancer (EOC) - Concepedia

Concepedia

Publication | Open Access

Neoadjuvant chemotherapy (NACT) increases immune infiltration and programmed death-ligand 1 (PD-L1) expression in epithelial ovarian cancer (EOC)

DOI Full Paper Access

171

Citations

20

References

2016

Year

Soizick Mesnage, Aurélie Auguste, Catherine Genestie, Ariane Dunant, Erwann Pain, Françoise Drusch, Sébastien Gouy, Philippe Morice, Enrica Bentivegna, C. Lhommé,

Annals of Oncology

Cancer ImmunosurveillanceNeoadjuvant ChemotherapyEpithelial Ovarian CancerMedicineImmunologyTumor ImmunityImmune InfiltrationImmune Checkpoint InhibitorCancer BiologyCancer TreatmentOncologyRadiation OncologyTumor MicroenvironmentEndocrine-related CancerOvarian Cancer

References

	Year	Citations

Page 1

Page 1